Felix Geissler
Plus aucun poste en cours
Historique de carrière de Felix Geissler
Anciens postes connus de Felix Geissler
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CURIS, INC. | Directeur Technique/Scientifique/R&D | 03/01/2022 | 01/01/2023 |
| Sanofi Corp. | Corporate Officer/Principal | - | - |
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Directeur Technique/Scientifique/R&D | - | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Directeur Technique/Scientifique/R&D | - | - |
Formation de Felix Geissler
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| University of Innsbruck | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Allemagne | 3 |
| Autriche | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 3 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
| Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Lumicell, Inc. develops and markets image-guided cancer surgery solutions. It offers Lumicell System, designed to enable surgeons to see residual cancer cells in the cavity walls in real-time during surgery. The company was founded by Linda G. Griffith, David G. Kirsch, Jorge M. Ferrer, Ralph Weissleder, W. David Lee, Andrey J. Zarur, and Moungi G. Bawendi in 2008 and is headquartered in Wellesley, MA. | Electronic Technology |
| Sanofi Corp. |
- Bourse
- Insiders
- Felix Geissler
- Expérience
